Targeting tumor-associated macrophage: an adjuvant strategy for lung cancer therapy

Overview of attention for article published in Frontiers in immunology, November 2023

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

So far, Altmetric has seen 11 X posts from 11 X users, with an upper bound of 67,950 followers.

RT @FrontImmunol: New Research: Targeting tumor-associated macrophage: an adjuvant strategy for lung cancer therapy: The emergence of immun…

RT @FrontImmunol: New Research: Targeting tumor-associated macrophage: an adjuvant strategy for lung cancer therapy: The emergence of immun…

RT @FrontImmunol: New Research: Targeting tumor-associated macrophage: an adjuvant strategy for lung cancer therapy: The emergence of immun…

RT @FrontImmunol: New Research: Targeting tumor-associated macrophage: an adjuvant strategy for lung cancer therapy: The emergence of immun…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 7 additional X posts.